Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
10.75
+0.27 (2.58%)
Aug 14, 2025, 2:23 PM - Market open
Phathom Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts that cover Phathom Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $16.4, which forecasts a 52.56% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $28.
Price Target: $16.4 (+52.56%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 9, 2025.
Analyst Ratings
The average analyst rating for Phathom Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +58.14% | Jun 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +86.05% | Jun 9, 2025 |
| Needham | Needham | Strong Buy Maintains $28 | Strong Buy | Maintains | $28 | +160.47% | Jun 6, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $19 → $12 | Strong Buy | Maintains | $19 → $12 | +11.63% | May 2, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $10 → $5 | Hold | Maintains | $10 → $5 | -53.49% | May 2, 2025 |
Financial Forecast
Revenue This Year
162.66M
from 55.25M
Increased by 194.40%
Revenue Next Year
330.57M
from 162.66M
Increased by 103.23%
EPS This Year
-3.53
from -5.29
EPS Next Year
-0.89
from -3.53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 181.3M | 387.7M | 636.9M | ||
| Avg | 162.7M | 330.6M | 548.4M | ||
| Low | 142.3M | 264.6M | 441.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 228.1% | 138.3% | 92.7% | ||
| Avg | 194.4% | 103.2% | 65.9% | ||
| Low | 157.5% | 62.7% | 33.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.06 | -0.25 | 1.42 | ||
| Avg | -3.53 | -0.89 | 1.18 | ||
| Low | -4.02 | -1.57 | 0.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.